Manufacturing Deficiencies Delay FDA Decision on Sutimlimab for Adults
News
The U.S. Food and Drug Administration (FDA) has issued a complete response to Sanofi’s application requesting that its investigational therapy sutimlimab be approved for treating hemolysis — the breakdown ... Read more